Related Experiment Videos
Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors
1Discovery Research, Berlex Biosciences, Richmond, CA 94804, USA. damian_arnaiz@berlex.com
Bioorganic & Medicinal Chemistry Letters
|June 15, 2000
Abstract:
A series of indole and carbazole based inhibitors of factor Xa (FXa) has been investigated. The most potent compound inhibits FXa with a Ki of 0.2 nM and has 900- and 750-fold selectivity over thrombin and trypsin, respectively.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Postoperative inflammatory markers are not associated with hidden blood loss after knee arthroscopy.
Frontiers in medicine·2026
[Analysis of the clinical epidemiological characteristics of rhinovirus in hospitalized children aged 14 years and younger with acute respiratory tract infection in a maternal and child health hospital in Hubei Province from 2023 to 2024].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
[Small tidal volume hyperventilation relieves intraocular and intracranial pressure elevation in prone spinal surgery: a randomized controlled trial].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
Bioorganic & medicinal chemistry letters·2026
Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair.
Bioorganic & medicinal chemistry letters·2026
Reactivation of an inert 15-mer antimicrobial peptide by truncation-directed i, i + 7 lactam cyclization.
Bioorganic & medicinal chemistry letters·2026
Semi-synthesis and activity study of α-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD.
Bioorganic & medicinal chemistry letters·2026
Caffeic acid phenethyl ester derivatives inhibit glyoxalase I activity and induce cell death in cultured cancer cell lines.
Bioorganic & medicinal chemistry letters·2026
Acetazolamide use in idiopathic intracranial hypertension: a real-world cohort study of side effects.
Expert review of neurotherapeutics·2026